COMPANY
ADVANZ PHARMA LIMITED
ADVANZ PHARMA LIMITED: marketing authorisation holder for Daptomycin, Lanreotide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Daptomycin | DAPTOMYCIN ADVANZ PHARMA 350 MG POWDER FOR SOLUTION FOR INJECTION OR INFUSION, PLGB 56734/0013, Authorised Regulator MHRA |
|---|---|
| Daptomycin | DAPTOMYCIN ADVANZ PHARMA 500 MG POWDER FOR SOLUTION FOR INJECTION OR INFUSION, PLGB 56734/0014, Authorised Regulator MHRA |
| Lanreotide | LANREOTIDE ADVANZ PHARMA 120 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 56734/0006, Authorised Regulator MHRA |
| Lanreotide | LANREOTIDE ADVANZ PHARMA 60 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 56734/0004, Authorised Regulator MHRA |
| Lanreotide | LANREOTIDE ADVANZ PHARMA 90 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 56734/0005, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.